|Ms. Helen Giza||CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG||3,21M||N/A||1968|
|Dr. Franklin W. Maddux F.A.C.P.||Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG||2,42M||N/A||1957|
|Mr. William J. Valle||Management Board Member for Care Delivery of Fresenius Medical Care Management AG||3,93M||N/A||1960|
|Dr. Katarzyna Mazur-Hofsab Ph.D.||Management Board Member for Care Enablement of Fresenius Medical Care Management AG||2,35M||N/A||1963|
|Mr. Roberto Fuste||Executive Advisor for Regional Strategy||N/A||N/A||1952|
|Mr. Martin Fischer||CFO & Member of the Management Board of Fresenius Medical Care Management AG||N/A||N/A||1977|
|Dr. Dominik Heger||Executive VP and Head of Investor Relations, Strategic Development & Communications||N/A||N/A||N/A|
|Mr. Borries Von Muller||Senior Vice President of Global Human Resources Employee Communications||N/A||N/A||1961|
|Mr. Joachim Weith||Senior Vice President of Corporate Communications & Governmental Affairs||N/A||N/A||N/A|
|Mr. Oliver Maier||Senior Vice President Investor Relations||N/A||N/A||N/A|
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co. KGaAs ISS Governance QualityScore, Stand 1. Dezember 2023, lautet 7. Die grundlegenden Scores sind Audit: 2, Vorstand: 4, Shareholderrechte: 1, Kompensation: 9.